This Trial is a Clinical Performance Validation Study That Will Evaluate the Clinical Agreement of the Sky Medical™ Rapid Antigen Test Comparing the Antigen Rapid Test to RT-PCR
NCT05491993 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2022-08-08
Summary
Prospective study that will evaluate the clinical agreement of the Sky Medical™ Rapid Antigen Test compared to SARS-CoV-2 RT-PCR.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Sky Medical™ Rapid Antigen Test
Rapid Antigen Diagnostic Test device performance comparative to RT-PCR.
Sponsors & Collaborators
-
Sky Medical Supplies & Equipments, LLC
lead INDUSTRY
Principal Investigators
-
Sri Madireddy, PhD
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-02-22
- Primary Completion
- 2023-01-11
- Completion
- 2023-01-11
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
NCT06113731 ·Status: RECRUITING ·Phase: PHASE2
-
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2
NCT05329220 ·Status: COMPLETED ·Phase: PHASE3
-
A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
NCT05652543 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Responses to COVID-19 Infection or Vaccination
NCT05379478 ·Status: COMPLETED
-
SafeTy and Efficacy of Preventative CoVID Vaccines
NCT05208983 ·Status: UNKNOWN
-
A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above
NCT05144139 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
NCT04551898 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years
NCT05522829 ·Status: UNKNOWN ·Phase: PHASE2
-
Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19
NCT05268939 ·Status: COMPLETED ·Phase: NA
-
A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults
NCT05923424 ·Status: COMPLETED ·Phase: PHASE1
-
Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence
NCT04582903 ·Status: RECRUITING
-
A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind
NCT05367908 ·Status: COMPLETED
-
A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses
NCT03362593 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for Hospitalized Adult Patients With COVID-19
NCT04426695 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults
NCT05142306 ·Status: COMPLETED ·Phase: PHASE1
-
Study Utilizing BIOZEK COVID-19 Antigen Rapid Test
NCT04926779 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV-2 Immune Responses After COVID-19 Therapy and Subsequent Vaccine
NCT04952402 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years
NCT05329051 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of SARS-CoV-2 Variant mRNA Vaccine in Healthy Participants
NCT05599802 ·Status: UNKNOWN ·Phase: PHASE1
-
Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19
NCT04519437 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
NCT06585241 ·Status: RECRUITING ·Phase: PHASE4
-
A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine
NCT05238454 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Immunogenicity Study of a SARS-CoV-2 (COVID-19) Variant Vaccine (mRNA-1273.351) in Naïve and Previously Vaccinated Adults
NCT04785144 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults
NCT02114268 ·Status: COMPLETED ·Phase: PHASE1
-
IMPACT OF THERAPEUTIC PLASMA EXCHANGE ON ACQUIRED VACCINAL ANTI-SARS-CoV-2 ANTIBODIES.
NCT05191394 ·Status: COMPLETED ·Phase: NA